lisocabtagene maraleucel
bms 
['breyanzi', 'lymphoma', 'bristol']
 updates:
at the #asco 2022, presented positive findings from the phase ii pilot study of #breyanzi in the patients with r/r large b-cell lymphoma for whom hematopoietic stem cell transplantation was not intended. explore more at: 
#DelveInsight is a premier Business Consulting and Market Research firm, focused exclusively on the healthcare industry